Home  >  News
Eppen_Research3neo_Feb26
you can get e-magazine links on WhatsApp. Click here
News
  Zydus receives US FDA Orphan Drug Designation for desidustat to treat sickle cell disease,   February 06, 2026
  Jubilant Pharmova in Q3 clocks 17% income growth at Rs. 2,143 crore, PAT up by 17%,   February 06, 2026
  Shukra Pharma to invest Rs. 600 core for a facility to manufacture surgical robotics and cancer therapy,   February 05, 2026
  Corona Remedies continues strong growth trajectory with 31% PAT surge in 9 months FY26,   February 05, 2026
  Akums Drugs & Pharma with the Chhanv Foundation engages with acid attack survivors at its Haridwar facility,   February 05, 2026
  PE fund 108 Bio Capital backs Pinwheel Therapeutics, commits $20 million for phase2b trial,   February 05, 2026
  Zydus receives US FDA tentative approval for dapagliflozin tablets, 5 mg and 10 mg,   February 04, 2026
  UP Pharma Conclave 1.0 highlights 'Lalitpur Bulk Drug Pharma Park' being developed on a hub-and-spoke model,   February 04, 2026
  P&G SEHAT flags off Mobile Healthcare Unit in Goa,   February 02, 2026
  Merck Healthcare R&D India unveils next-gen office in Bengaluru to power global innovation,   January 30, 2026
  Indoco Remedies receives US FDA final approval for its ANDA for lacosamide oral solution USP, 10 mg/mL,   January 30, 2026
  Swisslog Healthcare strengthens Asia Pacific growth ambitions with strategic expansion in India,   January 29, 2026
  Global tariff unpredictability: Economic Survey asks India Inc to learn from pharma industry experience,   January 29, 2026
  S&P Global upgrades Biocon Biologics Credit Rating to ‘BB+’ revises outlook to “stable”,   January 28, 2026
  Lupin receives highest ESG rating from CDP for climate change and water security,   January 27, 2026
  Alembic Pharma receives US FDA final approval for difluprednate ophthalmic emulsion,   January 27, 2026
  Venus Remedies receives second PLI incentive disbursement, reinforcing manufacturing strength,   January 27, 2026
  Akums strengthens presence in regulated markets with EU GMP approvals for 2 Haridwar plants,   January 23, 2026
  Lupin receives highest ESG rating from CDP for Climate Change and Water Security,   January 23, 2026
  Syngene International in Q3 revenues dip registering Rs. 932 crore and PAT slides by 44 per cent,   January 23, 2026

  • Results Found: 13150
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 658
 Back
 
ASIA_PHARMA_EXPO_2026
CPHI_Japan26
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram